HYPERCALCEMIA IN LIVER-TUMORS
- 1 January 1980
- journal article
- research article
- Vol. 92 (19) , 689-693
Abstract
In 32 patients with primary liver tumors, incidence and etiology of hypercalcemia were evaluated. Two patients revealed hypercalcemia from osteolytic metastases; 1 had coexistent primary hyperparathyroidism and in 1 patient hypercalcemia was pareneoplastic. The last 2 patients are presented in detail by case reports. Differential diagnostic problems appear often in patients in bad general condition, since invasive diagnostic methods are limited. The most potent substance to treat acute hypercalcemic syndrome is mithramycin. In those cases where surgical treatment is possible, complete resection of the primary liver tumor the adenoma of the parathyroid gland is recommended.This publication has 7 references indexed in Scilit:
- Parathyroid Hormone RadioimmunoassayAnnals of Internal Medicine, 1979
- Comparison of Commercially Available Parathyroid Hormone Immunoassays in the Differential Diagnosis of Hypercalcemia Due to Primary Hyperparathyroidism or MalignancyAnnals of Internal Medicine, 1979
- Carcinoma of the Breast Associated with Hypercalcemia and the Presence of Parathyroid Hormone-Like Substances in the Tumor*Journal of Clinical Endocrinology & Metabolism, 1979
- PRIMARY HYPERPARATHYROIDISM IN PARANEOPLASTIC HYPERCALCÆMIAThe Lancet, 1978
- Ectopic hyperparathyroidism (pseudohyperparathyroidism) in esophageal malignancyThe American Journal of Medicine, 1976
- MITHRAMYCIN INHIBITION OF RIBONUCLEIC ACID SYNTHESIS1966
- Hyperparathyroidism and CancerBMJ, 1964